AIDS in the United States

Slides:



Advertisements
Similar presentations
HIV Counseling, Testing and Referral (CTR) Services at Boston Medical Center Vanessa J. Sasso, MSW Manager, HIV CTR Program Center for HIV/AIDS Care and.
Advertisements

Implementing Rapid HIV Testing: Technologies, Legal and Cost Issues Vanessa Lee, MPH HIV Rapid Testing Coordinator CA Office of AIDS.
Rapid HIV Testing and Its Role in Advancing HIV Prevention: 2004 Update Bernard M. Branson, M.D. Chief, Lab Determinants and Diagnostics Section Centers.
Performance of Bio-Rad Genetic Systems HIV-1/HIV-2 Plus O EIA Followed by Multispot or OraQuick Advance in a Dual Immunoassay HIV Testing Strategy Laura.
Evaluation of HIV Rapid Diagnostic Devices National STD Prevention Conference San Diego, CA 6 March 2002 Jennifer A. Malia, MS, MT WRAIR.
Resolution of Discordant Confirmatory Results on POC Reactive Rapid Tests: Florida’s Pilot Project HIV Diagnostics: New Developments and Challenges Feb.
Rapid HIV Testing: 2005 Update Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Division of HIV/AIDS Prevention.
CDC Recommendations for HIV Testing of Adults and Adolescents Christina Price, MPH Delta Region AIDS Education and Training Center.
CLIA Waived Testing for Physician Office Labs Doris Thompson, Ph.D., MT (ASCP) AK State Public Health Laboratories State CLIA Program Francisca Lehr, M.S.,
An Introduction to HIV Incidence Surveillance (HIS) in California California Department of Public Health Office of AIDS.
1 Quality System Considerations for Over-The-Counter HIV Testing Devery Howerton, Ph.D. Chief, Laboratory Practice Evaluation and Genomics Branch, Division.
Primary HIV Infection: the CDC study Pragna Patel, MD MPH Medical Epidemiologist Behavioral and Clinical Surveillance Branch DHAP, CDC February 28, 2005.
Increasing Our Reach through Rapid HIV Testing Bernard M. Branson, M.D. Chief, Lab Determinants and Diagnostics Section Centers for Disease Control and.
Rapid HIV Testing in an Emergency Department Cook County Bureau of Health Services Chicago, Illinois Centers for Disease Control and Prevention (Cooperative.
Poster Presentation 40th Annual Meeting of IDSA Chicago, Illinois October 26, 2002 Presenting Author: Sabrina Kendrick, MD (312)
Michigan Birth Defects Registry Overview and Status.
Over The Counter HIV Testing A Technology Whose Time has Come Freya Spielberg, MD MPH
Oral Presentation 2002 National STD Prevention Conference San Diego, California March 6, 2002 Presenting Author: Karen Kroc (312)
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV, STD, and TB Prevention.
Guidelines for Laboratory Testing and Result Reporting for Antibody to Hepatitis C Virus Miriam J. Alter, Ph.D. Division of Viral Hepatitis Centers for.
APHL Survey HIV Diagnostic Testing Utilization Barbara G. Werner, PhD MA State Laboratory Institute February 28, 2005.
Implementing Rapid HIV Testing in New York State Mara San Antonio-Gaddy Director Bureau of Direct Program Operations NYSDOH, AIDS Institute.
HIV Screening and Women’s Health Health Care Education & Training, Inc. Originally developed by: Section 5: Test Options.
Is this Research? Exempt? Expedited?
QUALITY ASSURANCE Shree Baboolal 12 th February, 2005.
Roll-out and Implementation of Rapid Testing from a Field Perspective Perspectives from San Francisco Shelley Facente, MPH Rapid HIV Testing Program Coordinator.
Rapid HIV Testing: 2003 Update Bernard M. Branson, M.D. Chief, Lab Determinants and Diagnostics Section Centers for Disease Control and Prevention.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV/AIDS, Viral Hepatitis,
Implementing Rapid HIV Testing in the United States Bernard M. Branson, M.D. Centers for Disease Control and Prevention Overview and Background.
CLINICAL TRIAL OF THE HEMA-STRIP HIV RAPID TEST USING FINGERSTICK BLOOD, WHOLE BLOOD, PLASMA, AND SERUM Niel T. Constantine 1, Dan Bigg 2, Daniel Cohen.
Performance of rapid HIV tests used singly and in combination: Moving toward a point of care diagnosis. Kevin Delaney, MPH HIV Diagnostics: New Developments.
Epidemiology Tools and Methods Session 2, Part 1.
Figure 1 A Case Series of Discordant Laboratory Results with Statewide Rapid HIV Testing in New Jersey Eugene G Martin, PhD 1, Gratian Salaru, MD 1, Sindy.
An Approach for a Rapid HIV Antibody Home-Use Oral Fluid Test 1 An Approach for a Rapid HIV Antibody Home-Use Oral Fluid Test OraSure Technologies, Inc.
*p
HIV Testing In Vermont Update 2007 Cathleen Harris, MD Fletcher Allen Health Care.
1 Long-term Care Vermont’s Approach Individual Supports Unit Division of Disability and Aging Services Department of Disabilities, Aging & Independent.
1 OraQuick ® ADVANCE ™ HIV 1/2 Antibody Test (Oral Fluid Specimen Type) Blood Products Advisory Committee Meeting March 10, 2006.
Implementing a Rapid HIV Testing Guideline for L&D NNEPQIN April 30, 2007.
ORAQUICK RAPID HIV TEST Medical Center of Louisiana Cynthia Eicher, MHS MT(ASCP)SBB Denise Friloux, RN, BSN, CIC.
Monitoring, supervision and quality control IDSP training module for state and district surveillance officers Module 11.
Christopher N. Greene, PhD Newborn Screening and Molecular Biology Branch, Division of Laboratory Sciences NCEH, CDC Tuesday, 28th June 2011 Molecular.
HIV INCIDENCE SURVEILLANCE (HIS) PROGRAM California Department of Public Health Office of AIDS Surveillance Section.
Approaches to Validation of Over-the- Counter (OTC) Home-Use HIV Test Kits Blood Products Advisory Committee November 3, 2005 Elliot P. Cowan, Ph.D. Chief,
Introduction to OraQuick Rapid HIV Testing William F. Ryan Community Health Center School Based Health Program.
Who makes up all these rules?? A discussion on Regulatory Agencies and how they relate to each other and our lab.
I have no relevant financial relationships with the manufacturers of any commercial products and/or provider of commercial services discussed in this CME.
American Society for Microbiology Position on Home Use HIV-1 Testing Patricia Charache, MD Johns Hopkins Medical Institutions Professor of Pathology, Medicine.
Update Rapid HIV Test Approval Requirements and Standards BPAC September 15, 2000 Kimber Poffenberger, Ph.D.
Proposed Studies to Support the Approval of Over-the-Counter (OTC) Home-Use HIV Test Kits Blood Products Advisory Committee March 10, 2006 Elliot P. Cowan,
Regulatory requirements: children, assent, and consent waivers and waiver of documentation Bob Craig, 2007.
FLORIDA HOSPITAL-EMPLOYEE HEALTH PREVENTION OF SHARPS INJURIES AND EXPOSURE TO BLOOD AND BODY FLUIDS MICHELLE SCARLETT AND MARIE DECEUS.
© Guidant 2005 Surrogate Endpoints and Non-randomized Trials Roseann White Humble Biostatistician.
CLIA Waiver for the OraQuick ® Rapid HIV-1 Antibody Test Elliot P. Cowan, Ph.D. Senior Regulatory Scientist Office of Blood Research and Review Center.
Practice Key Driver Diagram. Chapter Quality Network ADHD Project Jeff Epstein PhD CQN ADHD National Expert/CQN Data Analyst The mehealth Portal and CQN.
HIV Testing in Acute Care Settings Rich Rothman, MD, PhD, FACEP CDC, DHHS, OraSure Technologies, Abbott  Historical.
Over The Counter HIV Testing Estimating The Public Health Benefit – Recommendations for Required Accuracy Freya Spielberg, MD MPH
CONCLUSIONS New Jersey’s Emergency Department HIV testing sites report higher seroprevalence than non-ED testing sites. Since University Hospital began.
15283 New Sensitive and Specific Rapid HSV-2 Antibody Test Objective To describe the performance and uses of a new HSV-2 specific serological rapid test,
Introduction to Quality Assurance. Quality assurance vs. Quality control.
Matilu Mwau, M.D., MTM, D.Phil(Oxon)
Point of Care Testing California Clinical Laboratory Association
California Clinical Laboratory Association
Get Ready for FDA Oversight of Laboratory Developed Tests Presenter:
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
Content and Labeling of Tests Marketed as Clinical “Whole-Exome Sequencing” Perspectives from a cancer genetics clinician and clinical lab director Allen.
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
Quality System Considerations for Over-The-Counter HIV Testing
Quality Control Barbara Weberman MT(ASCP)
Presentation transcript:

AIDS in the United States 1997 Consensus Conference Recommendations: Change PHS regulations, allow rapid test results SUDS test unacceptable Mandate to CDC: Make more rapid tests available Develop diagnostic algorithms using rapid tests 587,429 reported cases of AIDS in the United States

CDC Efforts and the Availability of Rapid Tests Based on identified public health need: Encourage manufacturers to commercialize rapid tests in the United States. Conduct clinical trials to establish test performance in settings of intended use. Provide data for PMA applications to speed FDA approval. Evaluate use of specific combinations of rapid tests to increase predictive value.

4/13/2019 Rapid Tests for HIV 4

Walter Reed Army Institute of Research HIV Diagnostic Laboratory 5

Results: Retrospective Study Walter Reed Army Institute of Research HIV Diagnostic Laboratory APHL Mar’ 2000

Seroconversion Panels 9th CROI, 2002

June 2001 BPAC: CLIA Waiver Should HIV rapid tests be eligible under standard CLIA criteria for waiver? In favor: CDC, NASTAD, CA Office of AIDS Prevention Programs Opposed: CLIAC, ASCP, ASM, AACC, ASCLS Concerns: Accuracy with untrained users; positive predictive value; confirmatory testing; quality control; counseling http://www.fda.gov/ohrms/dockets/ac/01/transcripts/3760t1_01.pdf

Methods 1: Untrained Users 4/13/2019 Methods 1: Untrained Users 130 participants from staff at HIV testing sites: 93 from Los Angeles testing site, 37 from Arizona STD clinic 129 hospital personnel: from Atlanta, Chicago, Miami, New Orleans, and New York The study was conducted in several parts. 130 participants were recruited from staff at HIV testing sites – 93 from the West Hollywood STD clinic and from the HIV testing clinic at the Los Angeles Gay and Lesbian Center. The participants each tested 3 serum specimens that had been obtained from patients. 37 participants were recruited from staff at the the Maricopa County STD clinic in Phoenix, Arizona. This group tested a panel of 4 plasma specimens that had been specially constructed to include negative, weak positive, and strong positive specimens. Rapid Tests for HIV

Invalid results were recorded for 37 (8.6% ) tests 4/13/2019 Results: Outcomes of 427 Tests Performed by 130 Untrained Users at HIV Testing Sites Invalid results were recorded for 37 (8.6% ) tests False Negative Correct At the HIV testing sites, participants performed a total of 427 tests. 37 of these (8.6%) were performed incorrectly, and a result of “invalid” was recorded. Participants obtained the correct result with 379 (97.2%) of the remaining 390 tests. Participants obtained incorrect (false-negative) results for 7 (1.8%) of the known positive specimens. All of these were with the weak-positive specimen, which showed a faint band on the test. Participants obtained false-positive results for 4 (1%) of the known negative specimens. 7 (1.8%) 379 (97.2%) False Positive 4 (1.0%) Rapid Tests for HIV

Invalid results were recorded for 50 (9.6% ) tests 4/13/2019 Results: Outcomes of 516 Tests Performed by 129 Untrained Health Care Workers Invalid results were recorded for 50 (9.6% ) tests Correct False Negative Results from the 129 untrained health care workers were similar. 50 (9.6%) of the 516 tests were performed incorrectly and gave an invalid result. Of the remaining 466 specimens, the rapid test result was correct for 448 (96.1%). There were 9 incorrect false-negative results, all with the weak-positive specimen, and 9 incorrect false-positive results. 9 (1.9%) 448 (96.1%) False Positive 9 (1.9%)* Rapid Tests for HIV

4/13/2019 Results: after Training: 5325 Tests Performed by 213 Health Care Workers Invalid 3 (0.06%) Correct False Negative Performance of the test improved considerably after a brief description and demonstration of the procedure. All participants correctly performed the test procedure. The supervising laboratory technician documented that the test was performed correctly in the 3 instances for which valid results were obtained. Thus, the invalid results were most likely due to a faulty device. Overall, the 213 participants obtained correct results for 99.7% of the 5300 tests they performed. 14 false-negative and 3 false-positive results were observed. 5305 (99.7%) 14 (0.26%) False Positive 3 (0.06%) Rapid Tests for HIV

Positive Predictive Value: Remember the tradeoffs… Good News: More HIV-positive people receive their test results. Bad News: Some people will receive a false-positive result before confirmatory testing.

Positive Predictive Value: Newborn Screening Specificity PPV PKU 99.7 2.65% Galactosemia 0.57% Hypothyroidism 98.3 1.77% Adrenal Hyperplasia 99.0 0.53% Newborn Screening results , 1993 Arch Pediatr Adolesc Med, July 2000

Overall, no statistically significant difference in STD incidence in HIV-negative persons after rapid HIV counseling vs standard 2-session counseling Behavior was similar in both groups Incidence of new STD 17-19% within 1 year

Role of the AD for Lab Diagnostics

The argument that less-than-perfect waived testing is better than none in some cases carries special weight when battling HIV. “If you have a population where 30 percent of people don’t come back to get their results, as the CDC says is true for people testing for HIV in certain settings, then you can never have a senxitivity [for any test] tat’s greater than 70 percent.” - Sheldon Campbell, MD, PhD CAP Point-of-Care Testing Committee

Collect oral fluid specimens by swabbing gums with test device. Reduce hazards, facilitate testing in field settings

Read results in 10 minutes Positive Negative Read results in 10 minutes

HIV-1 & HIV-2 Positive Negative Reactive Control Recombinant HIV-1 Peptide HIV-2 Peptide HIV-1 HIV-1 & HIV-2 Positive Negative